Infosys disappointed in FY24 with slow revenue growth, weak guidance, and shrinking headcount. Despite TCV of new deals, the company faces pressure. Stock weakness expected due to lackluster guidance and margin contraction.
Positive factors that could support the uptrend include record-high GST revenue, FIIs and DIIs being net buyers, and WTI oil prices falling below $80 a
Stocks that were in focus include names like Star Health, which rose 1.69%, M&M, which increased 4.63%, and Tata Chemicals, whose shares declined 2.49% on
Advertiser Disclosure
Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.
Disclaimer
It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.
Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003